Literature DB >> 9721971

Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients.

G Angarano1, P Maggi, S L Coppola, R L Cavaliere.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9721971     DOI： 10.1007/bf01709465

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  10 in total

1.  Prevalence of Leishmania infection among AIDS patients.

Authors:  J Alvar; B Gutiérrez-Solar; R Molina; R López-Velez; A Garcia-Camacho; P Martinez; F Laguna; E Cercenado; A Galmes
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

2.  Maintenance itraconazole for visceral leishmaniasis in HIV infection.

Authors:  A Lafeuillade; P Chaffanjon; E Delbeke; R Quilichini
Journal:  Am J Med       Date:  1992-04       Impact factor: 4.965

3.  The need for new therapeutic approaches in visceral leishmaniasis during HIV infection.

Authors:  A Lafeuillade; R Quilichini; C Dhiver; C Mary; J A Gastaut
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

4.  Cutaneous leishmaniasis in an AIDS patient: cure with itraconazole.

Authors:  G Pialoux; C Hennequin; B Dupont; P Ravisse
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

5.  Treatment of cutaneous leishmaniasis with oral itraconazole.

Authors:  E Van den Enden; A Van Gompel; A Stevens; N Vandeghinste; D Le Ray; P Gigase; K De Beule; J Van den Ende
Journal:  Int J Dermatol       Date:  1994-04       Impact factor: 2.736

6.  A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis.

Authors:  D Borelli
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

7.  Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.

Authors:  C Montalban; J L Calleja; A Erice; F Laguna; B Clotet; D Podzamczer; J Cobo; J Mallolas; M Yebra; A Gallego
Journal:  J Infect       Date:  1990-11       Impact factor: 6.072

8.  Cutaneous leishmaniasis. Treatment with itraconazole.

Authors:  G Albanese; P Giorgetti; L Santagostino; D Crippa; G Sala
Journal:  Arch Dermatol       Date:  1989-11

9.  Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.

Authors:  E Ribera; I Ocaña; J de Otero; E Cortes; I Gasser; A Pahissa
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965

10.  HIV-Leishmania co-infections in Italy. Isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients.

Authors:  M Gramiccia; L Gradoni; M Troiani
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Mar-Apr       Impact factor: 2.184
  10 in total
  5 in total

1.  Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.

Authors:  Patricia Barragán; Rogelio López-Velez; Montserrat Olmo; Daniel Podzamczer
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

Review 2.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 3.  Therapeutic options for visceral leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 4.  Visceral leishmaniasis and HIV coinfection in the Mediterranean region.

Authors:  Begoña Monge-Maillo; Francesca F Norman; Israel Cruz; Jorge Alvar; Rogelio López-Vélez
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

Review 5.  A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?

Authors:  Johan van Griensven; Ermias Diro; Rogelio Lopez-Velez; Koert Ritmeijer; Marleen Boelaert; Ed E Zijlstra; Asrat Hailu; Lutgarde Lynen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.